Rebecca Marshall, President & CEO
Ms. Marshall serves as President of CellectCell and Director with Medtown Ventures, with a specialty in Biologics and Regenerative Medicine. She is a well-rounded executive with over 18 years of experience in the medical device industry, most recently as Executive Director of Osteobiologics for RTI Biologics. During her professional career, Ms. Marshall has held leadership roles in R&D, Quality Assurance, Marketing and Business Development. She has significant experience in project management, product development, process development, business development, marketing, and sales training. Ms. Marshall is adept at building and developing both teams and strategies, solving problems and driving results.
Ms. Marshall began her career in the R&D department at Regeneration Technologies. After several roles of increasing responsibility, she was promoted to Group Manager of Product Development, and launched 12 new products in 3 years before transitioning into an executive role in Marketing / Business Development as the company completed an acquisition and became RTI Biologics. In that role, Ms. Marshall negotiated more than 10 key contracts including licensing agreements, supply and distribution agreements, and contract manufacturing agreements, and managed all aspects of the OEM business with annual revenue of $55 million. She commercialized a new stem cell bone graft platform, and for 3 consecutive years, grew the direct-to-hospital Osteobiologics business by more than 50% annually.
Ms. Marshall received an MBA, M.S and B.S. from the University of Florida.